IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Genmab
Neonc Technologies, Inc.
Inhibrx Biosciences, Inc
Iovance Biotherapeutics, Inc.
GlaxoSmithKline
Rutgers, The State University of New Jersey